HOME >> BIOLOGY >> NEWS
Landmark obesity study

Trials in mice are promising; human testing on horizon

Denver--August 30, 1999 - Scientists at Denver's Eleanor Roosevelt Institute have discovered a novel method for treating obesity in mice, a finding that could lead to new pharmaceutical treatments for overweight people worldwide. Published in the September issue of the international journal, Nature Medicine, the finding is a dramatic departure from most current obesity research, which concentrates on controlling appetite. This new approach centers on the way in which the body stores and burns fat.

The finding is tied to a gene known as POMC, which is found in both mice and humans. POMC provides signals that are important both during development and also later in life. The team was originally studying the impact of POMC on the development of the brain when they discovered it also played a major role in weight regulation.

"Our research demonstrates that mice lacking POMC-derived signals are obese," said Miles B. Brennan, a scientist at the Institute. "When we treated obese mice with a hormone made by the POMC gene, called MSH, they returned to almost normal weight in a matter of weeks. Further the effect isn't simply a change in appetite, but also in fat storage."

"We continue to do follow-up research in mice and the results are promising so far," said Brennan. "We hope to pair up with a strategic partner that will help move this study in to human clinical trials. If this process works in humans, we hope to get it to the public in the most efficient and timely way possible."

This discovery has implications for many diseases, explained Eleanor Roosevelt Institute President David Patterson. "For example, many people with Down syndrome have difficulty controlling their weight. In addition, medications commonly used to treat epilepsy and various forms of depression often lead to unwanted weight g
'"/>

Contact: Stephanie Donoho
donoho@eri.uchsc.edu
303-336-5641
Eleanor Roosevelt Institute
30-Aug-1999


Page: 1 2

Related biology news :

1. Landmark gene agreement announced by Samoan government and UC Berkeley for anti-AIDS drug Prostratin
2. Landmark agreement between Samoa and UC Berkeley could help search for AIDS cure
3. Landmark, pivotal Phase IIb/III trial of biotoxin for cancer pain begins
4. Landmark conference for United Nations on human cloning and stem cell research
5. Landmark study offers new information about breast cancer genes
6. Landmark completion of comprehensive index of human proteins to be presented at New York Academy of Sciences
7. Radical discovery dedicated a National Historic Chemical Landmark
8. Landmark progress in understanding ribosome structure-- research done at Brookhaven Labs light source
9. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
10. 16 APS exercise research highlights, from reduced flu mortality to proteomics & obesity
11. Marathoning mice could have Olympian effects on obesity

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... July 08, 2020 , ... Overcoming Comparability Issues in ... FDAnews Webinar, Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/cellandgenetherapy ... most effective way to complete one? Will the study comply with all FDA ...
(Date:7/2/2020)... Md. (PRWEB) , ... July ... ... Molecular Biology Systems, B.V. (MBS) has announced a publication detailing the use ... one-step reverse transcription polymerase chain reaction (RT-PCR) in 16 minutes. The article, ...
(Date:6/28/2020)... ... , ... In an upcoming episode scheduled for the fall of 2020, Advancements ... (POCT). Check local listings for more info. , Today, the majority of testing is ... labs throughout the country. Results are then available several days later. Now, in an ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... 16, 2020 , ... After research model surgery and catheter implantation, the long ... only the beginning of a successful study, while protecting and accessing the catheter or ... Head of Surgery from Envigo in a live webinar on ...
(Date:7/10/2020)... BALTIMORE (PRWEB) , ... July ... ... Baltimore biotechnology company, announced today that Massachusetts Institute of Technology (MIT) has ... This broader license allows PathSensors to move into the point-of-care diagnostic market, ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... growth of 40% in 2020, despite many obstacles created as a result of ... increase revenue for its partnered medical practices and medical manufacturers by expanding access ...
(Date:6/28/2020)... Conn. (PRWEB) , ... June 25, 2020 , ... ... formed to advance photodynamic therapy for treating cancer, today announced the company has ... York (“Roswell Park”). The agreement provides Lumeda globally exclusive rights to Roswell ...
Breaking Biology Technology:
Cached News: